Wells Fargo’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Hold
0
-$143 7191
2024
Q1
Hold
0
6577
2023
Q4
Hold
0
6720
2023
Q3
Sell
-1
Closed -$656 6668
2023
Q2
$803 Sell
1
-1
-50% -$776 ﹤0.01% 6380
2023
Q1
$1.66K Buy
2
+1
+100% +$872 ﹤0.01% 6259
2022
Q4
$2.63K Sell
1
-1
-50% -$396 ﹤0.01% 5940
2022
Q3
$2K Hold
2
﹤0.01% 6159
2022
Q2
$2K Sell
2
-3
-60% -$4.71K ﹤0.01% 6335
2022
Q1
$18K Sell
5
-6
-55% -$15.7K ﹤0.01% 6050
2021
Q4
$34K Buy
+11
New +$51K ﹤0.01% 6146
2021
Q3
Hold
0
6493
2021
Q2
Sell
-3
Closed -$47.2K 6342
2021
Q1
$50K Sell
3
-27
-90% -$527K ﹤0.01% 5814
2020
Q4
$516K Sell
30
-3
-9% -$56.4K ﹤0.01% 4495
2020
Q3
$620K Sell
33
-10
-23% -$230K ﹤0.01% 4194
2020
Q2
$1.13M Buy
43
+36
+514% +$1.02M ﹤0.01% 3720
2020
Q1
$161K Sell
7
-10
-59% -$160K ﹤0.01% 4812
2019
Q4
$160K Sell
17
-4
-19% -$38.6K ﹤0.01% 5080
2019
Q3
$199K Buy
21
+16
+320% +$195K ﹤0.01% 4965
2019
Q2
$80K Sell
5
-1
-17% -$16.6K ﹤0.01% 5395
2019
Q1
$126K Sell
6
-2
-25% -$35.5K ﹤0.01% 5052
2018
Q4
$97K Sell
8
-153
-95% -$2.65M ﹤0.01% 5293
2018
Q3
$3.96M Sell
161
-3
-2% -$91.4K ﹤0.01% 2845
2018
Q2
$5.64M Buy
164
+19
+13% +$729K ﹤0.01% 2571
2018
Q1
$5.75M Buy
145
+30
+26% +$1.14M ﹤0.01% 2517
2017
Q4
$5.3M Buy
115
+49
+74% +$2.29M ﹤0.01% 2531
2017
Q3
$3.75M Buy
+66
New +$3.62M ﹤0.01% 2782

Other funds holding KALA

Wells Fargo's KALA Position: Q2 2024 in Review

Wells Fargo held its KALA BIO (KALA) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7191.

Wells Fargo first reported a position in KALA in Q3 2017 and has held it in 22 quarters since. The position peaked at $5.75M in Q1 2018. 25 funds tracked by Wall St. Rank hold KALA as of Q2 2024.

  • Wells Fargo held 0 shares of KALA BIO worth $0 as of Q2 2024.
  • Wells Fargo left its KALA BIO share count unchanged in Q2 2024.
  • KALA BIO made up ﹤0.01% of Wells Fargo's portfolio in Q2 2024, its #7191 holding.
  • Wells Fargo first reported a position in KALA BIO in Q3 2017 and has held it in 22 quarters since.
  • Wells Fargo's KALA BIO position peaked at $5.75M in Q1 2018.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.